Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 SEK | +0.50% | +10.48% | +82.95% |
May. 16 | Diamyd Medical AB Updates on the Registrational Phase 3 Trial | CI |
Apr. 18 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
Business Summary
Number of employees: 26
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +20.26% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +20.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulf Hannelius
CEO | Chief Executive Officer | 49 | 16-04-09 |
Founder | 83 | 95-12-31 | |
Anna Styrud
DFI | Director of Finance/CFO | 63 | 09-12-31 |
Christoph Nowak
CTO | Chief Tech/Sci/R&D Officer | 38 | 20-12-31 |
Anton Lindqvist
CTO | Chief Tech/Sci/R&D Officer | 44 | 12-12-31 |
Martina Widman
COO | Chief Operating Officer | 43 | 16-08-31 |
Markus Jerling
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
Eva Karlström
LAW | General Counsel | 60 | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 83 | 95-12-31 | |
Director/Board Member | 63 | 11-12-31 | |
Director/Board Member | 52 | 21-04-27 | |
Director/Board Member | 76 | 17-03-31 | |
Director/Board Member | 54 | 08-12-31 | |
Mark Atkinson
BRD | Director/Board Member | 63 | 18-11-14 |
Karin Rosen
BRD | Director/Board Member | 57 | 23-03-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,741,630 | 0 | 0 | 63.20 % |
Stock B | 1 | 92,206,366 | 60,009,544 ( 65.08 %) | 0 |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+82.95% | 112M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- DMYD B Stock
- Company Diamyd Medical AB